DAFNA Capital Management LLC - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 1 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$11,843,000
-37.9%
587,456
+15.0%
3.14%
-21.2%
Q2 2021$19,061,000
+26.8%
510,756
-13.1%
3.99%
+11.8%
Q1 2021$15,029,000
+16.1%
587,7560.0%3.57%
-7.4%
Q4 2020$12,948,000
+58.4%
587,756
+29.4%
3.85%
+45.1%
Q3 2020$8,172,000
-29.2%
454,2360.0%2.66%
-20.2%
Q2 2020$11,538,000
+325.1%
454,236
+207.5%
3.33%
+193.9%
Q1 2020$2,714,000
+4.1%
147,714
+24.8%
1.13%
+26.6%
Q4 2019$2,606,000
+53.4%
118,3140.0%0.90%
+40.1%
Q3 2019$1,699,000
-8.8%
118,3140.0%0.64%
-8.7%
Q2 2019$1,863,000
+3.1%
118,314
-4.1%
0.70%
-10.3%
Q1 2019$1,807,000
+42.6%
123,314
+4.1%
0.78%
+23.8%
Q4 2018$1,267,000
-29.9%
118,5000.0%0.63%
-15.1%
Q3 2018$1,808,000
+34.1%
118,500
+7.7%
0.74%
+17.6%
Q2 2018$1,348,000
+92.3%
110,000
-7.8%
0.63%
+29.3%
Q3 2016$701,000
+95.8%
119,3000.0%0.49%
+71.8%
Q2 2016$358,000
-44.6%
119,300
-1.1%
0.28%
-49.0%
Q1 2016$646,000
-54.9%
120,6000.0%0.56%
-56.4%
Q4 2015$1,432,000
+41.2%
120,600
-2.3%
1.28%
+26.9%
Q3 2015$1,014,000
-16.3%
123,500
+42.3%
1.01%
-1.8%
Q2 2015$1,211,00086,8001.02%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,813,392$67,676,00017.58%
Bain Capital Life Sciences Investors, LLC 3,080,237$114,954,0007.53%
RTW INVESTMENTS, LP 7,521,859$280,716,0004.24%
DAFNA Capital Management LLC 510,756$19,061,0003.99%
SILVERARC CAPITAL MANAGEMENT, LLC 229,892$8,580,0003.83%
Parkman Healthcare Partners LLC 304,686$11,371,0002.49%
Evolutionary Tree Capital Management, LLC 141,324$5,274,0002.43%
Eagle Health Investments LP 161,125$6,013,0002.06%
Lombard Odier Asset Management (Switzerland) SA 636,011$23,736,0001.20%
Woodline Partners LP 1,000,325$37,332,0000.70%
View complete list of DICERNA PHARMACEUTICALS INC shareholders